NASDAQ: ATAIAtai Life Sciences Nv Stock Ownership - Who owns Atai Life Sciences Nv?
Insider buying vs selling
Have Atai Life Sciences Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Apeiron Investment Group Ltd | 10% Owner | 2025-03-24 | 1,800,000 | $1.40 | $2.52MBuy |
| Kevin James Craig | Chief Medical Officer | 2025-03-21 | 11,563 | $1.35 | $15.61kSell |
| Anne Nagengast Johnson | Chief Financial Officer | 2025-03-21 | 33,545 | $1.35 | $45.29kSell |
| Glenn Frank Short | Chief Scientific Officer | 2025-03-21 | 13,161 | $1.35 | $17.77kSell |
| Sahil Kirpekar | Chief Business Officer | 2025-03-21 | 48,563 | $1.35 | $65.56kSell |
| Srinivas Rao | Co-Founder and Chief Executive Officer | 2025-03-21 | 75,418 | $1.35 | $101.81kSell |
| Apeiron Investment Group Ltd | 10% Owner | 2025-02-14 | 10,835,718 | $2.10 | $22.76MBuy |
ATAI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ATAI insiders and whales buy or sell their stock.
ATAI Shareholders
What type of owners hold Atai Life Sciences Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Apeiron Investment Group Ltd | 22.05% | 44,168,717 | $120.58M | Insider |
| Christian Angermayer | 13.88% | 27,805,200 | $75.91M | Insider |
| Ubs Group Ag | 2.76% | 5,535,482 | $15.11M | Institution |
| Morgan Stanley | 1.64% | 3,293,535 | $8.99M | Institution |
| Pale Fire Capital Se | 1.29% | 2,592,584 | $7.08M | Institution |
| Davidson Kempner Capital Management LP | 0.71% | 1,413,443 | $3.86M | Institution |
| Millennium Management LLC | 0.57% | 1,135,752 | $3.10M | Institution |
| D E Shaw Co Inc | 0.50% | 993,361 | $2.71M | Institution |
| Moore Capital Management LP | 0.48% | 952,380 | $2.60M | Institution |
| Brown University | 0.36% | 718,500 | $1.96M | Institution |
ATAI vs Biotech Stocks
Atai Life Sciences Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.